Kainova reports positive top line results from Phase I EPRAD trial

​Kainova Therapeutics has reported positive top line results from the Phase I EPRAD study of DT-9081 in patients with advanced, recurrent, and metastatic solid tumours.

The post Kainova reports positive top line results from Phase I EPRAD trial appeared first on Hospital Management.

 

Back to the Featured Stories

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.